摘要 |
<p>Compounds of Formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, and compounds as shown in Formula (I) wherein C is for example (D), (E), (F); wherein A and B are independently selected from (i) and (ii); R2a to R3b are independently selected from hydrogen and fluorine; R1a and R1b are independently selected from, for example, hydroxy,—NHC(═W)R4, (a) and (b); wherein W is O or S; R4 is, for example, hydrogen, amino, (1-4C)alkyl; HET-1 is, for example, a C-linked 5-membered heteroaryl ring; HET-2 is, for example, an N-linked 5-membered, fully or partially unsaturated heterocyclic ring; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.</p> |
申请人 |
ASTRAZENECA AB |
发明人 |
GRAVESTOCK, MICHAEL, BARRY;HALES, NEIL, JAMES;SWAIN, MICHAEL, LINGARD;HAUCK, SHEILA, IRENE;MILLS, STUART, DENNETT |